Technical Analysis for ALDX - Aldeyra Therapeutics, Inc.

Grade Last Price % Change Price Change
D 11.57 -1.53% -0.18
ALDX closed down 1.53 percent on Thursday, April 15, 2021, on 58 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical ALDX trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
20 DMA Resistance Bearish -1.53%
50 DMA Resistance Bearish -1.53%
MACD Bearish Signal Line Cross Bearish 1.85%
Down 3 Days in a Row Weakness 1.85%
Fell Below 20 DMA Bearish -1.20%
Fell Below 50 DMA Bearish -1.20%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.90%
Overbought Stochastic Strength -3.90%
Older End-of-Day Signals for ALDX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 20 hours ago
60 Minute Opening Range Breakdown about 21 hours ago
10 DMA Resistance about 21 hours ago
Down 2 % about 21 hours ago
50 DMA Resistance about 21 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aldeyra Therapeutics, Inc. (Aldeyra) is a biotechnology company. The Company is focused primarily on the development of products to treat immune-mediated, inflammatory, orphan, and other diseases that are thought to be related to a naturally occurring toxic chemical species known as free aldehydes. The Company is developing NS2. NS2 is a product candidate that is designed to trap and allow for disposal of free aldehydes, for the treatment of diseases, which include Sjogren-Larsson Syndrome (SLS), discoid lupus, acute anterior uveitis and ocular rosacea with meibomian gland dysfunction. Aldeyra is also developing aldehyde traps distinct from NS2. As of April 7, 2014, it had evaluated NS2 in a Phase I clinical trial in 48 volunteers.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Diseases Organ Systems Autoimmune Diseases Rare Diseases Dysfunction Syndromes Lupus Rosacea Uveitis Inflammatory Discoid Lupus Meibomian Gland Ns2 Systemic Lupus Erythematosus

Is ALDX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.6178
52 Week Low 2.5
Average Volume 826,567
200-Day Moving Average 8.45
50-Day Moving Average 11.97
20-Day Moving Average 11.75
10-Day Moving Average 12.08
Average True Range 0.79
ADX 12.83
+DI 17.69
-DI 22.02
Chandelier Exit (Long, 3 ATRs ) 10.48
Chandelier Exit (Short, 3 ATRs ) 12.49
Upper Bollinger Band 12.93
Lower Bollinger Band 10.58
Percent B (%b) 0.42
BandWidth 19.95
MACD Line 0.01
MACD Signal Line 0.06
MACD Histogram -0.0429
Fundamentals Value
Market Cap 449.15 Million
Num Shares 38.8 Million
EPS -2.00
Price-to-Earnings (P/E) Ratio -5.79
Price-to-Sales 0.00
Price-to-Book 4.02
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.62
Resistance 3 (R3) 12.68 12.38 12.45
Resistance 2 (R2) 12.38 12.12 12.36 12.39
Resistance 1 (R1) 11.98 11.95 11.83 11.92 12.33
Pivot Point 11.68 11.68 11.61 11.66 11.68
Support 1 (S1) 11.28 11.42 11.13 11.22 10.81
Support 2 (S2) 10.98 11.25 10.96 10.75
Support 3 (S3) 10.58 10.98 10.70
Support 4 (S4) 10.52